<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02171897</url>
  </required_header>
  <id_info>
    <org_study_id>TREMLET AOI 2013</org_study_id>
    <nct_id>NCT02171897</nct_id>
  </id_info>
  <brief_title>Pertrochanter Arthroplasty Versus Osteosynthesis</brief_title>
  <acronym>PAVO</acronym>
  <official_title>Comparison of Functional Recovery After Pertrochanter Fracture Treated With Either Total Hip Replacement or Centromedullary Nailing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      This is a single-centre, comparative, prospective randomised trial. It will include 70
      patients over a period of 2 years randomized into two groups of 35 patients: one group of
      patients treated with osteosynthesis (plate, nail or screw) and the second group treated with
      total hip replacement.

      The Harris and PMA functional scores will be assessed at 6 weeks, 3 months, 6 months and 1
      year.

      The time to recovery of weight-bearing, the subjective satisfaction score, the EQ5D quality
      of life questionnaire, the VAS score for pain at rest and when walking, the Parker score, the
      rate of complications and deaths will also be measured. Operating time, blood loss and scar
      size will also be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Harris Score</measure>
    <time_frame>At 6 months after surgery</time_frame>
    <description>Functional hip score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PMA functional score</measure>
    <time_frame>Up to 1 year after surgery</time_frame>
    <description>Functional score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to recovery of weight-bearing</measure>
    <time_frame>Up to 1 year after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective satisfaction score (EQ5D, VAS score for pain at rest and when walking)</measure>
    <time_frame>Up to 1 year after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parker score</measure>
    <time_frame>Up to 1 year after surgery</time_frame>
    <description>Score autonomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complications (loosening of implants, fractures around osteosynthesis devices or prostheses, infections, phlebitis-pulmonary embolism)</measure>
    <time_frame>Up to 1 year after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death rate</measure>
    <time_frame>Up to 1 year after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Pertrochanter Fracture</condition>
  <arm_group>
    <arm_group_label>Patients treated with osteosynthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients treated with total hip replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Osteosynthesis</intervention_name>
    <arm_group_label>Patients treated with osteosynthesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total hip replacement</intervention_name>
    <arm_group_label>Patients treated with total hip replacement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided written informed consent

          -  Patients over 18 years old

          -  Patients less than 70 years old

          -  Patient presenting with a fracture of the trochanter (type 1 to 6 according to the
             Ender classification, and A1 and A2 according tyo the AO classification (Association
             suisse pour l'étude de l'Ostéosynthèse : classification internationale)

        Exclusion Criteria:

          -  Adult under guardianship

          -  Patients not covered by national health insurance

          -  Pregnant or breast-feeding women

          -  Unable to walk independently before the trauma

          -  Patients with dementia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Ludovic LABATTUT</last_name>
    <phone>3 80 29 33 74</phone>
    <phone_ext>+33</phone_ext>
    <email>ludovic.labattut@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de DIJON</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludovic LABATTUT</last_name>
      <phone>3 80 29 33 74</phone>
      <phone_ext>+33</phone_ext>
      <email>ludovic.labattut@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2014</study_first_submitted>
  <study_first_submitted_qc>June 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2014</study_first_posted>
  <last_update_submitted>June 20, 2014</last_update_submitted>
  <last_update_submitted_qc>June 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

